MEDNAX, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MEDNAX, Inc. - overview
Established
1979
Location
Sunrise, FL, US
Primary Industry
Outsourcing
About
MEDNAX, Inc. is a healthcare services provider specializing in neonatal, maternal-fetal, and pediatric specialties, delivering essential physician services to improve care quality across various medical environments. Founded in 1979, MEDNAX, Inc. operates from Sunrise, Florida, US, focusing on providing physician services in neonatology and other pediatric specialties.
The company was involved in a significant acquisition by Radiology Partners, Inc. in December 2020, which valued MEDNAX at USD 885 mn and aimed to enhance its service offerings. The CEO is James Swift, who leads the company in its strategic initiatives. MEDNAX offers a comprehensive range of healthcare services, primarily in the areas of neonatology, radiology, anesthesiology, and pediatric cardiology.
These services are designed to address critical healthcare needs in both hospital and outpatient settings, serving clients including hospitals and health systems throughout the United States. In 2024, MEDNAX reported a revenue of USD 1,201,291,900 with an EBITDA of USD -36,487,000, generated through service agreements with healthcare providers and structured around service-based fees tied to the volume of services provided. MEDNAX plans to leverage its recent funding acquisition from Radiology Partners, Inc. to enhance its service offerings and expand geographically.
The funding is expected to support the development of new healthcare solutions, targeting expansion into additional markets and regions by 2025. The company is exploring innovative approaches to improve pediatric healthcare and strengthen its operational framework following the strategic acquisition.
Current Investors
Radiology Partners
Primary Industry
Outsourcing
Sub Industries
Recruitment/Executive Search, Healthcare
Website
www.mednax.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
MEDNAX, Inc. - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,588,248,000 | 1,816,612,000 | 2,154,012,000 | 2,438,913,000 | 2,779,996,000 | 3,183,159,000 | 3,458,312,000 | 3,647,123,000 | 3,513,542,000 | 1,733,951,000 | 1,911,191,000 | - | - | - |
| % Revenue Growth (YoY) | - | 14.4% | 18.6% | 13.2% | 14.0% | 14.5% | 8.6% | 5.5% | (3.7%) | (50.6%) | 10.2% | - | - | - |
| EBITDA (USD) | 380,681,000 | 420,336,000 | 492,097,000 | 558,989,000 | 622,096,000 | 665,767,000 | 588,469,000 | 561,701,000 | (1,051,517,000) | 133,736,000 | 239,400,000 | - | - | - |
| Operating Income (USD) | 355,389,000 | 389,520,000 | 452,131,000 | 512,999,000 | 557,868,000 | 571,687,000 | 480,076,000 | 445,848,000 | (1,136,049,000) | 98,132,000 | 202,918,000 | - | - | - |
| Operating Margin | 22.4% | 21.4% | 21.0% | 21.0% | 20.1% | 18.0% | 13.9% | 12.2% | (32.3%) | 5.7% | 10.6% | - | - | - |
| % EBITDA Margin | 24.0% | 23.1% | 22.8% | 22.9% | 22.4% | 20.9% | 17.0% | 15.4% | (29.9%) | 7.7% | 12.5% | - | - | - |
| NET Income (USD) | 217,997,000 | 240,907,000 | 280,517,000 | 317,203,000 | 335,691,000 | 324,596,000 | 320,372,000 | 268,629,000 | (1,497,702,000) | (796,488,000) | 130,937,000 | - | - | - |
| % Net Margin | 13.7% | 13.3% | 13.0% | 13.0% | 12.1% | 10.2% | 9.3% | 7.4% | (42.6%) | (45.9%) | 6.9% | - | - | - |
MEDNAX, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | American Anesthesiology, Inc. | - | ||||||||
| Buyout | Completed | Elevate Patient Financial Solutions, LLC | - | ||||||||
| Add-on | Completed | NICS | - | ||||||||
| Trade Sale | Completed | Medical Anesthesia Consultants Medical Group, Inc. | - | ||||||||
| Trade Sale | Completed | Virtual Radiologic | - |
Displaying 1 - 5 of 9
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.